Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #40,601 to #40,650.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Capillary leak syndrome surgery (2 revisions)
  2. Capillary refill (2 revisions)
  3. Capitate bone (2 revisions)
  4. Caplans syndrome case study one (2 revisions)
  5. Caplans syndrome cost-effectiveness of therapy (2 revisions)
  6. Caplans syndrome future or investigational therapies (2 revisions)
  7. Caprin-1 (2 revisions)
  8. Capromab pendetide (2 revisions)
  9. Capsule (2 revisions)
  10. Captain Cutaneum (2 revisions)
  11. Captopril (patient information) (2 revisions)
  12. Captopril challenge test (2 revisions)
  13. Caput medusae (2 revisions)
  14. Carbacephem (2 revisions)
  15. Carbamoyl phosphate (2 revisions)
  16. Carbamoyl phosphate synthase II (2 revisions)
  17. Carbamoyl phosphate synthetase I deficiency (2 revisions)
  18. Carbapenem (2 revisions)
  19. Carbazole (2 revisions)
  20. Carbenicillin indanyl sodium adverse reactions (2 revisions)
  21. Carbenicillin indanyl sodium clinical pharmacology (2 revisions)
  22. Carbenicillin indanyl sodium dosage and administration (2 revisions)
  23. Carbenicillin indanyl sodium indications and usage (2 revisions)
  24. Carbenicillin indanyl sodium microbiology (2 revisions)
  25. Carbide (2 revisions)
  26. Carbidopa/levodopa (2 revisions)
  27. Carbimazole (2 revisions)
  28. Carbohydrate-responsive element-binding protein (2 revisions)
  29. Carbohydrate (chondroitin 4) sulfotransferase 13 (2 revisions)
  30. Carbol fuchsin (2 revisions)
  31. Carbon-carbon bond (2 revisions)
  32. Carbon group (2 revisions)
  33. Carbonic anhydrase 4 (2 revisions)
  34. Carbonic anhydrase 7 (2 revisions)
  35. Carbonic anhydrase III, muscle specific (2 revisions)
  36. Carbonyl (2 revisions)
  37. Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (2 revisions)
  38. Carboplatin (patient information) (2 revisions)
  39. Carboxypenicillin (2 revisions)
  40. Carboxypeptidase B2 (2 revisions)
  41. Carcinoma (2 revisions)
  42. Carcinoma in situ (2 revisions)
  43. Carcinoma of the penis electrocardiogram (2 revisions)
  44. Cardiac action potential (2 revisions)
  45. Cardiac allograft vasculopathy laboratory findings (2 revisions)
  46. Cardiac amyloidosis causes (2 revisions)
  47. Cardiac amyloidosis cost-effectiveness of therapy (2 revisions)
  48. Cardiac amyloidosis other diagnostic studies (2 revisions)
  49. Cardiac amyloidosis risk factors (2 revisions)
  50. Cardiac catheterization pre-procedure evaluation (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)